會通股份(688219.SH):擬2000萬元參投美智二期
格隆匯6月27日丨會通股份(688219.SH)公佈,為更好地藉助資本市場優勢推動公司在改性材料等領域的戰略探索,探尋產業發展方向,公司擬藉助專業投資機構的經驗、能力和資源,以推動公司產品向未來產業等下游市場開拓,同時實現管理資本的長期穩定增值,實現公司和股東收益最大化。公司擬參投美智二期(廣東)創業投資合夥企業(有限合夥)(簡稱“美智二期”),合夥企業認繳出資總額為33,452萬元,公司作為有限合夥人以自有資金出資人民幣2,000萬元。本基金主要投向新材料、新能源、核心零部件、先進裝備與智能製造、人工智能、大數據、雲計算領域。本基金投資於以上約定的產業領域比例不得低於本基金總實繳出資總額的60%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.